Arrowhead Pharmaceuticals
ARWR
#1965
Rank
โ‚ฌ9.07 B
Marketcap
64,39ย โ‚ฌ
Share price
0.15%
Change (1 day)
372.79%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2025 (TTM): 0,35ย โ‚ฌ

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is 0,30ย โ‚ฌ. an increase over its 2024 EPS that were of -4,32ย โ‚ฌ.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2025

Annual EPS

Year EPS Change
2025-0,008641ย โ‚ฌ-99.8%
2024-4,32ย โ‚ฌ161.39%
2023-1,65ย โ‚ฌ17.36%
2022-1,41ย โ‚ฌ19.85%
2021-1,18ย โ‚ฌ61.9%
2020-0,73ย โ‚ฌ-216.67%
20190,62ย โ‚ฌ-210.77%
2018-0,56ย โ‚ฌ38.3%
2017-0,41ย โ‚ฌ-64.93%
2016-1,16ย โ‚ฌ-16.25%
2015-1,38ย โ‚ฌ28%
2014-1,08ย โ‚ฌ-3.85%
2013-1,12ย โ‚ฌ-31.58%
2012-1,64ย โ‚ฌ331.82%
2011-0,38ย โ‚ฌ-51.11%
2010-0,78ย โ‚ฌ-79.07%
2009-3,72ย โ‚ฌ-37.68%
2008-5,96ย โ‚ฌ-16.87%
2007-7,17ย โ‚ฌ38.33%
2006-5,18ย โ‚ฌ122.22%
2005-2,33ย โ‚ฌ42.11%
2004-1,64ย โ‚ฌ533.33%
2003-0,26ย โ‚ฌ-99.08%
2002-28,06ย โ‚ฌ25%
2001-22,44ย โ‚ฌ33.33%
2000-16,83ย โ‚ฌ-120.51%
199982,08ย โ‚ฌ-400%
1998-27,36ย โ‚ฌ-81.48%
1997-147,75ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
7,55ย โ‚ฌ 2,396.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-7,04ย โ‚ฌ-2,428.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
5,44ย โ‚ฌ 1,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
3,27ย โ‚ฌ 982.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-2,49ย โ‚ฌ-922.86%๐Ÿ‡บ๐Ÿ‡ธ USA